Global Artificial Saliva Market Share Report 2024, Forecast To 2033
22 Aug, 2024
The artificial saliva market has grown rapidly, expanding from $1.72 billion in 2023 to $1.95 billion in 2024 at a CAGR of 13.6%. This growth is attributed to the increasing demand for oral sprays, oral gels, and oral liquids, as well as expanding treatment options for cancer patients and a growing aging population. The market is expected to reach $3.27 billion by 2028 at a CAGR of 13.8%, driven by rising awareness about oral hygiene, the prevalence of dry mouth syndrome, and increasing demand for artificial saliva products. Key trends include advancements in product formulation, integration with advanced technologies, and a shift towards natural and biocompatible ingredients in dry mouth treatments.
Global Artificial Saliva Market Key Driver
The artificial saliva market is expected to grow due to the rising prevalence of dry mouth syndrome. Dry mouth syndrome, or xerostomia, is characterized by a persistent feeling of dryness in the mouth, often caused by an aging population and widespread medication use. Artificial saliva alleviates this condition by moisturizing oral tissues. For example, a study by Faculdade Meridional in Brazil found a 19.1% prevalence rate of xerostomia among older adults in 2021. Similarly, research by the University of Gothenburg found a 43.6% prevalence rate in a 2022 survey of adult patients. Therefore, the rising prevalence of dry mouth syndrome is driving the growth of the artificial saliva market.
Get A Free Sample Of The Artificial Saliva Market ReportGlobal Artificial Saliva Market Segments
The artificial saliva market covered in this report is segmented –
1) By Product: Oral Spray, Oral Solution, Oral Liquid, Dissolving Tablets, Gel, Powder
2) By Distributional Channel: Supermarkets, Hypermarkets, Other Distribution Channels
3) By End-User: Adult, Pediatric
By Geography:The regions covered in the artificial saliva market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the artificial saliva market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
Major Artificial Saliva Industry Players
Pfizer Inc., Amgen Inc., Viatris Inc., Bausch Health Companies Inc., Perrigo Company plc, Aurobindo Pharma, Cipla, Hikma Pharmaceuticals plc, RECORDATI, Mankind Pharma Ltd., Quantum Health Inc., Mission Pharmacal Company, Cumberland Pharmaceuticals Inc., DENTAID, Parnell Pharmaceuticals Inc., Forward Science, ICPA Health Products Ltd., Saliwell Ltd., Livealth, CCMed Ltd., Nanochemazone
Purchase The Global Artificial Saliva Market Report Directly And Get A Swift DeliveryArtificial Saliva Market Overview
Artificial saliva refers to a synthetic product designed to mimic the properties and functions of natural saliva. It is used to relieve dryness in the mouth (xerostomia) caused by various conditions such as Sjögren's syndrome, radiation therapy for cancer, or certain medications. Artificial saliva helps to moisten and lubricate the mouth, aids in chewing and swallowing, and can improve overall oral comfort.
Artificial Saliva Global Market Report 2023 provides data on the global artificial saliva market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The artificial saliva market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.